CluenexConcentrix CNXC
Concentrix scores weak on business quality (3.6 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Concentrix does
Concentrix provides customer experience solutions and technology services to global enterprises, generating revenue through outsourced operational contracts. The company is leaning into digital modernization initiatives to capture enterprise demand.
- What it does best
Concentrix delivers high-volume customer engagement services with a gross margin of 34.0%, outperforming peer MMS at 25.6%. This scale allows it to absorb operational complexities that smaller rivals cannot match efficiently.
- The main risk
A debt-to-equity ratio of 1.7 creates substantial interest overhead, with interest coverage sitting thin at 2.4x. If revenue growth stalls further, debt service will squeeze operational flexibility.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin sits at 6.8% while net margin is negative at -13.2% due to heavy net losses of $1.3B. Scale has not translated into expanding margins.
The company relies on customer switching costs tied to integrated enterprise workflows. However, an operating margin in the 24th sector percentile limits the depth of this moat.
Revenue growth registers at 2.2%, tracking in the bottom quartile of its sector at the 15th percentile. This marks a clear deceleration from historical expansion rates.
Total debt stands at $4.6B against $327M in cash, leaving net debt at $4.3B. Free cash flow reached $514M, but tight interest coverage of 2.4x makes the balance sheet softer.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on CNXC
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Concentrix scores weak on the Cluenex quality check (3.6 of 10), measured against its own industry. Profitability is weak, moat fair, growth steady and financial health weak.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Jan 11, 2027, after the close.
See CNXC today
- Today's verdict on CNXC, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Concentrix (CNXC)”, https://cluenex.com/stocks/cnxc/, data as of Oct 10, 2026.